Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

WHWK Whitehawk Therapeutics, Inc.

盘前交易 02-12 06:13:16 EST

2.83

+0.02

+0.71%

最高2.85	最低2.72	成交量2.02万
今开2.84	昨收2.81	日振幅4.63%
总市值1.33亿	流通市值6,161万	总股本4,713万
成交额5.67万	换手率0.09%	流通股本2,177万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":2.83,"timestamp":1770843600000,"preClose":2.81,"halted":0,"volume":20222,"delay":0,"changeRate":0.007117437722419935,"floatShares":21770230,"shares":47128362,"eps":-0.309934,"marketStatus":"盘前交易","change":0.02,"latestTime":"02-12 06:13:16 EST","open":2.84,"high":2.85,"low":2.72,"amount":56705.4849,"amplitude":0.046263,"askPrice":3.07,"askSize":100,"bidPrice":2.31,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.309934,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770906600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.83,"postHourTrading":{"tag":"盘后","latestPrice":2.83,"preClose":2.83,"latestTime":"16:04 EST","volume":2,"amount":5.66,"timestamp":1770843877042,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.1659300930386935,"impliedVol":2.6724,"impliedVolPercentile":1},"requestUrl":"/m/hq/s/WHWK","defaultTab":"news","newsList":[{"id":"2605407107","title":"Whitehawk Therapeutics, Inc.盘中异动 股价大跌5.61%报2.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605407107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605407107?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:52","pubTimestamp":1769179945,"startTime":"0","endTime":"0","summary":"北京时间2026年01月23日22时52分，Whitehawk Therapeutics, Inc.股票出现波动，股价急速下跌5.61%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Revelation Biosciences, Inc.、Coherus Oncology, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为525.66%、88.16%、16.15%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为60.41%、33.94%、26.67%。Whitehawk Therapeutics, Inc.公司简介：Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123225226a6a59661&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123225226a6a59661&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","WHWK","LENZ"],"gpt_icon":0},{"id":"2603521809","title":"Whitehawk Therapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603521809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603521809?lang=zh_cn&edition=full","pubTime":"2026-01-13 01:31","pubTimestamp":1768239115,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日01时31分，Whitehawk Therapeutics, Inc.股票出现异动，股价快速跳水5.30%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cellectar Biosciences, Inc.、Beam Therapeutics Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为642.52%、132.36%、100.72%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Mindwalk Holdings Corp.，振幅分别为32.48%、31.29%、31.25%。Whitehawk Therapeutics, Inc.公司简介：Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113013155a7127730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113013155a7127730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","WHWK","BK4539"],"gpt_icon":0},{"id":"2602830959","title":"Whitehawk Therapeutics, Inc.盘中异动 快速下挫5.90%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602830959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602830959?lang=zh_cn&edition=full","pubTime":"2026-01-10 02:21","pubTimestamp":1767982871,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日02时21分，Whitehawk Therapeutics, Inc.股票出现波动，股价大幅跳水5.90%。截至发稿，该股报2.55美元/股，成交量4.4599万股，换手率0.09%，振幅4.43%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Novabay Pharmaceuticals, Inc.、Cg Oncology, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为640.51%、78.12%、47.91%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Akoustis Technologies Inc、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为53.49%、38.11%、35.11%。Whitehawk Therapeutics, Inc.公司简介：Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011002211197a157d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011002211197a157d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WHWK","BK4539","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"1182864798","title":"WhiteHawk Therapeutics凭借Hwk-007的IND许可进入临床阶段，并宣布提交Hwk-016的IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1182864798","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182864798?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:07","pubTimestamp":1767877644,"startTime":"0","endTime":"0","summary":"生物制药公司WhiteHawk Therapeutics迎来重要里程碑，其候选药物Hwk-007已获得新药临床试验（IND）许可，标志着公司正式迈入临床开发阶段。与此同时，WhiteHawk Therapeutics还宣布已提交另一款候选药物Hwk-016的IND申请，进一步拓展其研发管线。\n这一进展凸显了公司在创新疗法开发上的持续动力，也为后续的临床研究奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139"],"gpt_icon":0},{"id":"2594282908","title":"Whitehawk Therapeutics, Inc.盘中异动 大幅上涨5.28%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594282908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594282908?lang=zh_cn&edition=full","pubTime":"2025-12-24 23:20","pubTimestamp":1766589646,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日23时20分，Whitehawk Therapeutics, Inc.股票出现异动，股价快速上涨5.28%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，奥麦罗制药、Indaptus Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 涨幅较大，Dermata Therapeutics, Inc.、Indaptus Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为1766.77%、1194.23%、59.51%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Citius Pharmaceuticals, Inc.、Indaptus Therapeutics, Inc.，振幅分别为62.58%、52.88%、32.82%。Whitehawk Therapeutics, Inc.公司简介：Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224232047953b9d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224232047953b9d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","WHWK","BK4539","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.whitehawktx.com","stockEarnings":[{"period":"1week","weight":-0.0241},{"period":"1month","weight":0.1012},{"period":"3month","weight":0.3541},{"period":"6month","weight":0.7687},{"period":"1year","weight":0.0481},{"period":"ytd","weight":0.1694}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":-0.0046},{"period":"3month","weight":0.0296},{"period":"6month","weight":0.0754},{"period":"1year","weight":0.1431},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Whitehawk Therapeutics, Inc.于2007年11月16日在特拉华州成立。该公司是一家临床阶段的生物制药公司，为基因定义的癌症开发精准疗法。该公司的主要目标是为mTOR通路驱动因子变化的癌症患者带来转化疗法，例如TSC1或TSC2基因的变化，而mTOR抑制剂由于药理学、有效药物递送、安全性或有效性问题而没有或不能得到有效利用。Aadi的主要产品是FYARROTM，这是一种mTOR抑制剂，可与人类蛋白质结合，并显示出更高的肿瘤积累、更大的mTOR靶点抑制和增强的肿瘤生长抑制。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.171513},{"month":2,"riseRate":0.375,"avgChangeRate":-0.027494},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.227585},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.018337},{"month":5,"riseRate":0.857143,"avgChangeRate":0.190811},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.069397},{"month":7,"riseRate":0.375,"avgChangeRate":-0.025419},{"month":8,"riseRate":0.625,"avgChangeRate":0.031865},{"month":9,"riseRate":0.625,"avgChangeRate":0.003135},{"month":10,"riseRate":0.125,"avgChangeRate":-0.092738},{"month":11,"riseRate":0.625,"avgChangeRate":0.077853},{"month":12,"riseRate":0.5,"avgChangeRate":-0.084464}],"exchange":"NASDAQ","name":"Whitehawk Therapeutics, Inc.","nameEN":"Whitehawk Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Whitehawk Therapeutics, Inc.(WHWK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Whitehawk Therapeutics, Inc.,WHWK,Whitehawk Therapeutics, Inc.股票,Whitehawk Therapeutics, Inc.股票老虎,Whitehawk Therapeutics, Inc.股票老虎国际,Whitehawk Therapeutics, Inc.行情,Whitehawk Therapeutics, Inc.股票行情,Whitehawk Therapeutics, Inc.股价,Whitehawk Therapeutics, Inc.股市,Whitehawk Therapeutics, Inc.股票价格,Whitehawk Therapeutics, Inc.股票交易,Whitehawk Therapeutics, Inc.股票购买,Whitehawk Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Whitehawk Therapeutics, Inc.(WHWK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Whitehawk Therapeutics, Inc.(WHWK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况